MASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patients

• Published in: Supportive care in cancer 2024-06, Vol.32 (6), p.335-335, Article 335
• Main Authors: Affronti, Mary Lou, Lee, Jiyeon, Molassiotis, Alex, Johnson, Lindsay, Tinianov, Stacey, Clark-Snow, Rebecca, Scotte, Florian
• Format: Article
• Language: English
• Subjects: Agreements; Antiemetics; Antiemetics - administration & dosage; Antiemetics - therapeutic use; Caregivers; Consensus; Delphi Technique; Evidence-Based Medicine; Humans; Medicine; Medicine & Public Health; Nausea; Nausea - prevention & control; Neoplasms - complications; Nursing; Nursing Research; Oncology; Pain Medicine; Patient education; Patient Education as Topic - methods; Patient Education as Topic - standards; Patient-centered care; Patient-Centered Care - methods; Practice Guidelines as Topic; Rehabilitation Medicine; Vomiting; Vomiting - prevention & control
• ISSN: 0941-4355; 1433-7339
• DOI: 10.1007/s00520-024-08543-x

Purpose The Multinational Association of Supportive Care in Cancer (MASCC)/European Society of Medical Oncology (ESMO) Patient Antiemetic Guideline Committee aimed to (1) adapt the updated evidence-based, clinical guidelines to patient-centered antiemetic guidelines and (2) develop patient education materials and statements. Methods The MASCC 2023 Patient Antiemetic Guidelines were created and reviewed by antiemetic experts and patient advocates by incorporating the 2023 MASCC/ESMO antiemetic guidelines into patient-friendly language. Patient Education Statements were developed based on current literature and by utilizing an expert modified Delphi consensus (≥ 75% agreement). Patient advocate/focus group input and patient survey results were further integrated into Patient-Centered Antiemetic Guidelines and Education Statements. Results Patient-Centered Antiemetic Guidelines were created using patient-friendly language and visual slides. Patient-friendly language was also utilized to communicate the Educational Statements. Key content categories identified for the Educational Statements included the following: nausea/vomiting definitions, causes, risk factors, categories, complications, accompanying symptoms, prophylactic antiemetic treatment, general management, when to call/what to ask the healthcare team, what caregivers can do, and available resources. All identified content met the ≥ 75% expert agreement threshold. Fifteen (15) items demonstrated 100% agreement, 11 items achieved ≥ 90% agreement, and three content items demonstrated 80 ~ 82% agreement. Conclusions The inaugural MASCC 2023 Patient Antiemetic Guidelines can help patients and caregivers understand the prevention of nausea and vomiting related to their cancer treatment. Educational Statements provide further patient information. Educating patients on how to utilize guideline antiemetics and the education statements can contribute improvements in the control of anticancer treatment-related nausea and vomiting.